Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
57
Number of overlapping holdings
43.8%
% of XBI's 131 holdings also in SBIO
66.3%
% of SBIO's 87 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XBI |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
NIVALIS THERAPEUTICS INC | 1.9% | 1.5% | 1.5% | |
REVOLUTION MEDICINES, INC. | 1.3% | 3.1% | 1.3% | |
CEREVEL THERAPEUTICS HOLDINGS INC | 1.2% | 4.8% | 1.2% | |
CRINETICS PHARMACEUTICALS INC | 1.2% | 2.1% | 1.2% | |
GERON CORP | 1.1% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to SBIO
BIOMARIN PHARMACEUTICAL INC | 1.2% | |
CYTOKINETICS INC | 1.2% | |
EXACT SCIENCES CORP | 1.2% | |
EXELIXIS INC | 1.2% | |
MODERNA, INC. | 1.1% | |
AMGEN INC | 1.1% | |
ROIVANT SCIENCES LTD. | 1.1% | |
UNITED THERAPEUTICS CORP | 1.1% | |
ALNYLAM PHARMACEUTICALS INC | 1.1% | |
NATERA INC | 1.1% |
XBI Underweight Relative to SBIO
VIKING THERAPEUTICS, INC. | -4.3% | |
CEREVEL THERAPEUTICS HOLDINGS INC | -3.6% | |
VAXCYTE, INC. | -3.6% | |
AXSOME THERAPEUTICS, INC. | -2.3% | |
XENON PHARMACEUTICALS INC. | -2.0% | |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.9% | |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -1.9% | |
ALKERMES PLC | -1.9% | |
REVOLUTION MEDICINES, INC. | -1.8% | |
ARVINAS, INC. | -1.8% |